BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  Sierra Oncology Reports First Quarter 2019 Results

  Sierra Oncology, Inc. reported its financial and operational results for the first quarter ended March 31, 2019.

  May 8, 2019

   · 

  12 min read
• Deals

  Protagonist Therapeutics Reports First Quarter 2019 Financial Results

  Protagonist Therapeutics, Inc. reported its financial results for the first quarter ended March 31, 2019.

  May 8, 2019

   · 

  8 min read
• Business

  GVK BIO Announces the Appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.

  GVK BIO is pleased to announce the appointment of Dr. Axel Schleyer as Chief Executive Officer, Aragen Bioscience Inc.

  May 8, 2019

   · 

  3 min read
• Business

  Gilead Sciences and Goldfinch Bio Announce Strategic Collaboration to Develop Novel Therapies for Kidney Disease

  Companies to Pursue a Human Genetics Approach to Drug Discovery and Development

  May 8, 2019

   · 

  5 min read
• Genetown

  ArQule to Present at the Bank of America Merrill Lynch 2019 Health Care Conference on May 15, 2019

  ArQule, Inc. announced that Peter Lawrence, President and Chief Operating Officer, and Dr. Marc Schegerin, Chief Financial Officer and Head of Strategy, will present at the Bank of America Merrill Lynch 2019 Health Care Conference on May 15, 2019 at 3:15 p.m. PT at the Encore Hotel in Las Vegas, NV.

  May 8, 2019

   · 

  2 min read
• Deals

  Rocket Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights

  Rocket Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2019, and provides an update on the Company’s recent achievements, as well as upcoming milestones.

  May 8, 2019

   · 

  10 min read
• Business

  AstraZeneca Teams Up with PGA Golf Champion Jason Day to Raise Awareness about the Importance of Biomarker Testing in Lung Cancer

  Test It Back campaign encourages patients newly diagnosed with non-small cell lung cancer to ensure they receive a full diagnosis and the treatment that is right for them

  May 8, 2019

   · 

  4 min read
• Business

  TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference

  TherapeuticsMD, Inc. announced that the company will participate in the Bank of America Merrill Lynch 2019 Health Care Conference.

  May 8, 2019

   · 

  3 min read
• IMV Joins World Ovarian Cancer Coalition and Ovarian Cancer Canada in Supporting Ovarian Cancer Day 2019

  IMV Inc. joins with World Ovarian Cancer Coalition and Ovarian Cancer Canada in recognizing World Ovarian Cancer Day.

  May 8, 2019

   · 

  4 min read
• Policy

  ReForm Biologics Announces Issuance of U.S. Patent on Stabilizing Excipients for Therapeutic Protein Formulations

  New class of excipients offers a promising alternative to polysorbates for stabilizing proteins

  May 8, 2019

   · 

  2 min read